(19)
(11) EP 2 510 903 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
25.04.2018 Bulletin 2018/17

(45) Mention of the grant of the patent:
21.03.2018 Bulletin 2018/12

(21) Application number: 12175392.5

(22) Date of filing: 27.06.2008
(51) International Patent Classification (IPC): 
A61F 2/00(2006.01)
 A61B 17/00(2006.01)

(54)

Non-continuous pelvic implant

Diskontinuierliches Beckenimplantat

Implant pelvien non continu

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(30) Priority: 29.06.2007 US 947044 P

(43) Date of publication of application:
17.10.2012 Bulletin 2012/42

(62) Application number of the earlier application in accordance with Art. 76 EPC:
08779807.0 / 2170217

(73) Proprietor: Boston Scientific Scimed, Inc.
Maple Grove, MN 55311 (US)

(72) Inventors:
  • Montpetit, Karen Pilney
    Mendota Heights, MN Minnesota 55118 (US)
  • Chapman, Kelly Ann
    Altadena, CA California 91001 (US)

(74) Representative: Pfenning, Meinig & Partner mbB 
Patent- und Rechtsanwälte Joachimsthaler Straße 10-12
10719 Berlin
10719 Berlin (DE)


(56) References cited: : 
EP-A1- 2 649 961
WO-A2-2006/069078
WO-A2-2007/149555
US-A- 5 368 602
 WO-A1-2008/013867
WO-A2-2007/149348
DE-U1-202006 016 866
US-B1- 6 575 897
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).